Exploring how CRISPR gene editing and AI are transforming medicine with breakthrough therapies and diagnostic tools.
Exploring the democratic challenges of CRISPR gene editing technology and the need for inclusive deliberation in biotechnology governance
Exploring how SWATH® Acquisition on TripleTOF® systems enables comprehensive protein-level validation of CRISPR edits and reveals proteome-wide changes.
Exploring the challenges of regulating rapidly evolving biotechnologies like CRISPR and AI-assisted gene editing in global policy frameworks.